Tune into this episode to hear a discussion on GDMT in heart failure and the gaps between the evidence and the practicality of implementation. Host Kevin Shah, MD, is joined by three HF providers across the career spectrum: Ted Berei, PharmD, Gregg C. Fonarow, MD, and Jonathan Davis, MD, MPH. The guests discuss the gap between trial-proven evidence-based heart failure therapies and implementation of these medications to our most vulnerable patients.

Guests: 

• Ted Berei, PharmD, Clinical Pharmacist, General Cardiology/Advanced Heart Failure - University of Wisconsin Hospitals and Clinics @chfpharmd
• Jonathan Davis, MD, MPH, Associate Professor, UCSF, Director of the Heart Failure Program, San Francisco Health Network (SFHN) @JonathanDavisHF
• Gregg C. Fonarow, MD, FHFSA, Eliot Corday Professor of Cardiovascular Medicine and Science at UCLA @gcfmd

Disclosures

• Ted Berei, PharmD - Consultant: Cytokinetics
   
• Jonathan Davis, MD, MPH - Consultant/Advisory Board: AstraZeneca 
   
• Gregg C. Fonarow, MD, FHFSA - Consultant/Advisory Board: Abbott, Amgen, AstraZeneca, Bayer, Cytokinetics, Edwards, Janssen, Medtronic, Merck, and Novartis